Foamix Pharmaceuticals Ltd. Net Cash Provided by (Used in) Continuing Operations
Foamix Pharmaceuticals Ltd. reported Net Cash Provided by (Used in) Continuing Operations of $71.94 million for the 9-month period ending 2018-09-30, per its 10-Q filed 2018-11-07.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:NetCashProvidedByUsedInContinuingOperations · last filed 2018-11-07
- Foamix Pharmaceuticals Ltd. net cash provided by (used in) continuing operations for the quarter ending 2018-09-30 was $76.17M.
- Foamix Pharmaceuticals Ltd. net cash provided by (used in) continuing operations for the quarter ending 2018-06-30 was -$1.04M, a 105.32% decline year-over-year.
- Foamix Pharmaceuticals Ltd. net cash provided by (used in) continuing operations for the quarter ending 2018-03-31 was -$3.19M.
- Foamix Pharmaceuticals Ltd. net cash provided by (used in) continuing operations for the quarter ending 2017-12-31 was -$4.85M.
- Foamix Pharmaceuticals Ltd. net cash provided by (used in) continuing operations for fiscal 2017 was -$15.28M, a 220.87% decline from fiscal 2016.
- Foamix Pharmaceuticals Ltd. net cash provided by (used in) continuing operations for fiscal 2016 was $12.64M.
- Foamix Pharmaceuticals Ltd. net cash provided by (used in) continuing operations for fiscal 2015 was -$24.21M.
| Period end | Net Cash Provided by (Used in) Continuing Operations 3 month | Net Cash Provided by (Used in) Continuing Operations 6 month | Net Cash Provided by (Used in) Continuing Operations 9 month | Net Cash Provided by (Used in) Continuing Operations 12 month |
|---|---|---|---|---|
| 2018-09-30 | $76.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $75.13M derived: sum of 2 quarters · filed 2018-11-07 | $71.94M 10-Q · filed 2018-11-07 | $67.09M derived: sum of 4 quarters · filed 2018-11-07 |
| 2018-06-30 | -$1.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | -$4.23M 10-Q · filed 2018-08-08 | -$9.08M derived: sum of 3 quarters · filed 2018-08-08 | -$34.09M derived: sum of 4 quarters · filed 2018-11-07 |
| 2018-03-31 | -$3.19M 10-Q · filed 2018-05-08 | -$8.04M derived: sum of 2 quarters · filed 2018-05-08 | -$33.05M derived: sum of 3 quarters · filed 2018-11-07 | -$13.42M derived: sum of 4 quarters · filed 2018-11-07 |
| 2017-12-31 | -$4.85M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | -$29.86M derived: sum of 2 quarters · filed 2018-11-07 | -$10.23M derived: sum of 3 quarters · filed 2018-11-07 | -$15.28M 10-K · filed 2018-03-01 |
| 2017-09-30 | -$25.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | -$5.38M derived: sum of 2 quarters · filed 2018-11-07 | -$10.43M 10-Q · filed 2018-11-07 | |
| 2017-06-30 | $19.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $14.58M 10-Q · filed 2018-08-08 | ||
| 2017-03-31 | -$5.05M 10-Q · filed 2018-05-08 | |||
| 2016-12-31 | $12.64M 10-K · filed 2018-03-01 | |||
| 2015-12-31 | -$24.21M 10-K · filed 2018-03-01 | |||
| 2014-12-31 | $41.28M 20-F · filed 2017-02-21 | |||
| 2013-12-31 | $1.69M 20-F · filed 2016-03-02 | |||
| 2012-12-31 | -$641.00K 20-F · filed 2015-03-17 |